UNSPSC 51391738: Salmefamol

This classification denotes a beta-adrenergic agonist with the molecular formula C19H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q56SEY8X9J, chemically known as 1,3-benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((2-(4-methoxyphenyl)-1-methylethyl)amino)methyl)- but generally known as salmefamol, which bears US NIH Compound Identifier 86805. European Medicines Agency schedules Salmefamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10429MIG.

UNSPSC 51391738 Salmefamol, a Commodity code, nominally classifies a specific pharmaceutical product, but the recent state and local activity under this code does not align with its nominal scope. The single recent opportunity sourced shows Seminole County, Florida procuring naloxone and safe drug deactivation systems through an IFB posted June 30, 2026, with a response deadline of July 26, 2023 — a mismatch between the posting date and the deadline that signals either a data error or an archived record. The opportunity itself centers on community health and emergency response supplies, quantities (1,900 units of naloxone and 800 safe drug deactivation systems annually), and quarterly delivery logistics rather than salmefamol as a pharmaceutical line item. No other recent state and local opportunities appear in the sourcing block.

The code shows minimal recent activity relevant to state and local procurement. Seminole County's IFB is the only recent record and reflects a county health department or community health initiative rather than a pattern of comparable solicitations across jurisdictions. No geographic spread, repeat buyer pattern, or representative opportunity cluster exists to characterize here. Vendors should verify the UNSPSC coding accuracy with Seminole County or the sourcing platform before pursuing opportunities tagged under this code, as the mismatch between the nominal commodity and the actual procurement suggests either miscoding or a code assignment that does not reflect standard pharmaceutical procurement activity in the state and local market.